Adage Capital Partners Gp, L.L.C. Harmony Biosciences Holdings, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 500,000 shares of HRMY stock, worth $17.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
500,000
Previous 300,000
66.67%
Holding current value
$17.1 Million
Previous $12 Million
43.55%
% of portfolio
0.03%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$226 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$199 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$162 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$77.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$54 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.02B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...